WisdomTree Commodity Securities Limited (LWEA.GB) 시세

Nice!

Steve Mnuchin on CNBC TV coming up next ...

CPI lower than expected Dow futures respond positively +246

will there be any Fannie/Freddie Housing comments ? ...

prob more comments/focus on Tariffs and recession fears

VOIP-PAL.COM, INC. v. Verizon Communications, Inc. et al
Texas Western District Court
Judge: Alan D Albright
Case #: 6:21-cv-00672
Nature of Suit 830 Property Rights - Patent
Cause 35:271 Patent Infringement
Case Filed: Jun 25, 2021
Terminated: Aug 15

https://fintel.io/i/m28-capital-management-lp

almost 70% of M28 Capital is in WVE that is lead and advised John Maraganore, PhD. Alnylam Pharmaceuticals. Cambridge, MA. Brook ... M28 Capital Management.

$WVE

He is right!

Que?

Be careful with this one, they are about to be hit with a 268 bil anti-trust RICO lawsuit sometime this month.

GM LD!!

Just do some basic math boys at .00030 x 1,000000 shares equals a grand total of $300 for the subsidary!! Lmao 🤣 you can’t make this trash up it’s straight garbage just like the ceo and company!! Hell it’s going to costs more to make the sale in closing and attorneys lmao 🤣

Still sometimes getting the OPPS when going to my boards. Hit reload about 3 times and it appears even after I cleared the cookies and cache for this site. Moving between post once on the board seems to work fine, it's getting to the board(s) themselves that's the issue.

Complete BS that they entertain a question about potentially acquiring another product and don't say a word about the requested and shareholder approved buyback that could instantly enhance shareholder value and leverage upside to growth the company anticipates.

Up 7% premarket, inflation report came out and it looked like it cooled off in February. Investors like it, momentum is there for sure.

The definitive Purchase Agreement is expected to be executed no later than July 1, 2025. The agreement includes a $250,000 penalty clause, ensuring ASII's commitment to completing the transaction.

Grupo aval

Bots get the party started brother, cancer cure moment up ahead🚀🚀

Don't they have to get Shareholder approval to execute a reverse stock split?

$BURU News March 12, 2025
NUBURU Takes Strategic Leap Forward: First Acquisition Step in Defense and Security Sector Completed
https://finance.yahoo.com/news/nuburu-takes-strategic-leap-forward-123000363.html

Kool aide talk going great. Mounting legal bills against a real big pharmaceutical company, just looks appealing for a buyout. Lol. Get real. Now let's compare to other deals. Sub 12 cents is around the corner. Bridges are being built, who wants one?

By the looks of premarket there is the answer to your question as to why 1 for 20 rather than 1 for something lower.  As long as it doesn't drop below 5 cents before April 11 the new stock price will still be above a buck

Why would mgt. be doubling it’s efforts in a line item project srudying IPE?……..this is why the stock is undervalued, imo……

Have you been paying attention?

New formulation work, plus they specifically highlighted the potential of a synergy with GLP-1 receptors. That's h

HMTXF...089...🥳...OTC partnering with a NAZ company sounds proising to me...Calgary, Alberta--(Newsfile Corp. - March 6, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell company that has safely treated 498 patients for

NEWS: $ASII Accredited Solutions, Inc. (OTC: ASII) Engages Partner Capital Group, LLC (PartnerCap) to Explore Strategic Alternatives to Maximize Shareholder Value

Mar. 12, 2025 8:00 AM ET Source: Diamond Creek Water LLC.

NEW YORK, NY - March 12, 2025 (NEWMEDIAWIRE) - Ac

No shares, your own cry.

https://investorshub.advfn.com/uimage/uploads/2025/3/3/qzphsisopet.JPG

HMTXF...089...🥳...OTC partnering with a NAZ company sounds proising to me...Calgary, Alberta--(Newsfile Corp. - March 6, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Hemostemix" or "HEM"), an autologous angiogenic stem cell company that has safely treated 498 patients for